The studies correlating the clinical pathological parameters of breast cancer with MMR dysfunction suggest an association between MSI and poor clinico- pathological features namely: larger tumor size, positive nodal status, advanced stage, negative expression of hormone receptors and decreased disease free and overall survival [9,12-14]. This evidence concerns the gene NR4A1 and breast carcinoma.